Autotome Rx 49
Payments companies reported to CMS as associated with Autotome Rx 49. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Autotome Rx 49, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Autotome Rx 49
These are the largest totals companies reported as associated with Autotome Rx 49. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Isaac Raijman | Houston, TX | Gastroenterology (Internal Medicine) | $20,012.13 |
| Kalpesh Patel | Houston, TX | Gastroenterology (Internal Medicine) | $1,032.05 |
| Muhammad Hasan | Orlando, FL | Gastroenterology (Internal Medicine) | $903.37 |
| Raj Shah | Aurora, CO | Gastroenterology (Internal Medicine) | $901.81 |
| Salmaan Jawaid | Houston, TX | Gastroenterology (Internal Medicine) | $797.27 |
| Mohammad Bilal | Aurora, CO | Gastroenterology (Internal Medicine) | $760.41 |
| Ahmed Saeed | Kansas City, MO | Gastroenterology (Internal Medicine) | $708.73 |
| James Buxbaum | Los Angeles, CA | Gastroenterology (Internal Medicine) | $678.82 |
| Sherif Andrawes | Staten Island, NY | Gastroenterology (Internal Medicine) | $507.77 |
| Mouen Khashab | Baltimore, MD | Gastroenterology (Internal Medicine) | $434.52 |
Prescribed Autotome Rx 49?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.